GTC
LPCN icon

Ghost Tree Capital’s Lipocine LPCN Stock Holding History

Ghost Tree Capital’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,398
Closed -$561K – 76
2014
Q3 		$561K Buy
+5,398
New +$671K 0.3% 63

Other funds holding LPCN

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Ghost Tree Capital's LPCN Position: Q4 2014 in Review

Ghost Tree Capital sold out of Lipocine (LPCN) in Q4 2014, closing a stake of 5,398 shares — an estimated $561K sold.

Ghost Tree Capital first reported a position in LPCN in Q3 2014 and held it in 1 quarter. The position peaked at $561K in Q3 2014. 22 funds tracked by Wall St. Rank hold LPCN as of Q4 2014.

  • Ghost Tree Capital reported no remaining Lipocine position as of Q4 2014 after selling out during the quarter.
  • Ghost Tree Capital sold 5,398 Lipocine shares in Q4 2014, an estimated $561K.
  • Ghost Tree Capital first reported a position in Lipocine in Q3 2014 and held it in 1 quarter.
  • Ghost Tree Capital's Lipocine position peaked at $561K in Q3 2014.
  • 22 funds tracked by Wall St. Rank held Lipocine as of Q4 2014.

Based on Ghost Tree Capital's 13F filing for Q4 2014, filed 17 Feb 2015.